See Mun Wong, Digital and Quality Improvement Specialist, at SPS, presents a summary of the resources published by SPS between 25th and 31st October.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
Polypharmacy and Structured Medication Review Explainer Videos
These animated videos explain the 7 steps of structured medication review, using a person-centred approach to managing polypharmacy
https://www.sps.nhs.uk/articles/polypharmacy-and-structured-medication-review-explainer-videos/
Ex-Vivo and In-Vivo Non-GMO Gene Therapy Medicinal Products
This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing Ex-Vivo Non-Genetically Modified Organism Gene Therapies.
https://www.sps.nhs.uk/articles/ex-vivo-non-gmo-gene-therapy-medicinal-products-pharmacy-institutional-readiness-guidance/
Prescribing Outlook
Our annual medicines planning publication, Prescribing Outlook was updated on October 30th. Please note that Sacubitril-valsartan has been added to the patent expiries tab. To view the correction in the spreadsheet, pleas log in to the website
https://www.sps.nhs.uk/wp-content/uploads/2025/10/Prescribing_Outlook_2025_amended_October_2025_v2.xlsx#:~:text=Prescribing_Outlook_2025_(amended_October_2025)_v2
New Spotlight Digest
A digest of NHS Specialist Pharmacy Service support for professionals working in all areas of the healthcare system for October 2025.
https://www.sps.nhs.uk/articles/spotlight-october-2025/
National PGD template updates
Updated PGD templates for Doxycycline, oral Azithromycin in sexual health services, and Emtricitabine and tenofovir disoproxil for PrEP use.
https://www.sps.nhs.uk/wp-content/uploads/2025/10/Azithromycin-chlamydia-National-PGD-template-V3.0.docx#:~:text=National%20PGD%20template%20updates
https://www.sps.nhs.uk/wp-content/uploads/2025/10/Doxycycline-chlamydia-National-PGD-template-V3.0.docx#:~:text=National%20PGD%20template%20updates
TD-FTC Pre-Exposure Prophylaxis PrEP National PGD template V3.0 · 85.93 KB
Six intrathecal risk assessments have also been reviewed and updated, including those for Diamorphine, Etoposide, Methotrexate, gentamicin, rituximab and thiotepa.
https://www.sps.nhs.uk/articles/thiotepa-informing-intrathecal-risk-assessment/#:~:text=%20six%20intrathecal%20risk%20assessments
Etoposide: informing intrathecal risk assessment – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Rituximab: informing intrathecal risk assessment – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Methotrexate: informing intrathecal risk assessment – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Gentamicin: informing intrathecal risk assessment – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Diamorphine hydrochloride: informing intrathecal risk assessment – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Next events – forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
